H.R. 3839 · 118th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Stage
In committee
Sponsor
Neal Dunn
Introduced
2023-06-06
Latest action
2023-06-09 · Referred to the Subcommittee on Health.

Action history

  1. 2023-06-09Referred to the Subcommittee on Health.
  2. 2023-06-06Introduced in House
  3. 2023-06-06Referred to the House Committee on Energy and Commerce.